research Global Expression Profile and Genome Methylation Signatures in Male Patients with Androgenetic Alopecia
Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.
Search
for
Sort by
Research
540-570 / 1000+ results research An Update on the Pathophysiology of Female Pattern Hair Loss
Female pattern hair loss involves hair follicles shrinking, influenced by hormones like melatonin and prolactin.
research Quality of Life in Australian Women with Female Pattern Hair Loss
Female pattern hair loss negatively affects quality of life, and treatment does not improve it within two months.
research Telogen Effluvium
Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.
research Chronic Telogen Effluvium: Is It a Distinct Condition? A Systematic Review
Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.
research Trajectories for Scalp Hair Regrowth in Patients With Severe Alopecia Areata Treated With Baricitinib
Baricitinib helps patients with severe alopecia areata regrow hair.
research Reliability and Validity of a Measure to Assess the Health-Related Quality of Life of Women with Alopecia Areata
The tool to measure life quality for women with alopecia is reliable and accurate.
research Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss
Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.
research Advances in Hair Growth
The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.
research Diffuse Congenital Hypotrichosis Simplex with Associated Hair Shaft Fragility
The document's conclusion cannot be provided because the document is not available or cannot be understood.
research SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth
Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.
research Novel 'After Minoxidil' Spray Improves Topical Minoxidil Compliance and Hair Style Manageability
The "After Minoxidil" spray makes hair easier to style, less greasy, and encourages people to keep using the treatment.
research Bitemporal Alopecia Areata: Case Reports and Diagnostic Challenges
The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.
research Alopecia Universalis Treated with Simvastatin/Ezetimibe, Minoxidil, and Prednisolone in a 6-Year-Old Girl
A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.
research Female Pattern Hair Loss, Biological Aging, and the Leiden Longevity Study
Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.
research Limited Effectiveness of Platelet-Rich Plasma Treatment on Chronic Severe Alopecia Areata
Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.
research Epigenetic Modifications May Explain the Relative Protection of Occipital Hair Follicles from Androgenetic Alopecia in Men
research Oral Cyclosporin Does Not Arrest Progression of Androgenetic Alopecia
Oral cyclosporin doesn't stop hair loss.
research Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
Low-dose oral minoxidil may help with hair loss, but more research is needed.
research Long-Term Efficacy of Baricitinib in Alopecia Areata: 3-Year Results from BRAVE-AA1 and BRAVE-AA2
Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.
research Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials
Baricitinib helps long-term hair regrowth in severe alopecia areata patients.
research Dissecting Cellulitis of the Scalp in a Pediatric Male
A 13-year-old boy with a rare scalp condition improved significantly with isotretinoin, minoxidil, oral steroids, and antiseptic shampoo.
research Real-World Effectiveness and Safety of Tofacitinib for Alopecia Areata: A Retrospective Cohort Study of 202 Patients
Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.
research Novel Investigational Drugs for Alopecia Areata and Future Perspectives
JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.
research Low-Dose Oral Minoxidil Improves Hair Length and Global Hair Density in Short Anagen Syndrome
Low-dose minoxidil helps hair grow longer and thicker in people with short anagen syndrome.
research Long-Term Efficacy and Safety of Baricitinib in Patients With Severe Alopecia Areata: 104-Week Results From BRAVE-AA1 and BRAVE-AA2
Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.
research Treatment of Moderate-to-Severe Alopecia Areata in Patients Over the Age of 65 With Baricitinib
Baricitinib helps treat severe hair loss in people over 65.
research Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
research Visualizing Severity Of Alopecia Tool Scores In The Clinical Setting Using Patient Images From A Clinical Trial
The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.
research Clinical Benefits of Baricitinib Therapy for Severe Alopecia Areata
Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.